Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Study Phase
Phase 3
Study Completion Date
May 2007
NCT00115765Uploaded 08-03-2018
Available for Download
PDS UID: Colorec_Amgen_2005_262
PACCE: A Randomized, Open-Label, Controlled, Clinical Trial of Chemotherapy and Bevacizumab With and Without Panitumumab in the First-Line Treatment of Subjects With Metastatic Colorectal Cancer
PROTOCOL20040249_01.20.01 Protocol Amend 2 2007-08-07 English_Redacted.pdf
CRFAmgen 20040249 CRF REDACTED.pdf
DATA DICTIONARYAmgen 20040249 DDT.pdf